Open Orphan

Interim Results for 6 months ended 30 June 2020

by lynchski

Amryt Pharma – Grant Funding From Irish Government For AP103

Amryt

by lynchski

Amryt Pharma – LOJUXTA To Be Reimbursed In France

Amryt

by lynchski

Amryt Pharma – Interim Results

Amryt

by lynchski

Amryt Pharma - Amryt Receives Ind Approval From FDA for AP101

Amryt

by lynchski

Amryt Pharma – FDA Grants Pediatric Rare Disease Designation

Amryt

by lynchski

Amryt Pharma – Trading Update & Significant Momentum Building

Amryt

by lynchski

Amryt Pharma - NHS England Approves Funding For LOJUXTA

Amryt

by lynchski